Behavioural and psychosocial interventions for pain management

2021 ◽  
pp. 461-470
Author(s):  
Joseph G. Winger ◽  
Carolyn E. Keeler ◽  
Francis J. Keefe

Patients with advanced disease commonly report pain as one of their most feared and distressing symptoms. A biomedical treatment approach that focuses solely on biological factors can be helpful but often fails to adequately address important psychological, social, and spiritual factors that can contribute to pain. Behavioural and psychosocial approaches to understanding and treating pain in patients with advanced disease can be quite helpful in this context. These approaches not only have the potential to reduce pain but also improve patients’ overall adjustment to life-limiting disease. This chapter provides an overview of these approaches. It is divided into four sections, including a summary of the prevalence and undertreatment of pain in patients with advanced disease, a rationale for behavioural and psychosocial approaches to pain management, an overview of the most common and effective behavioural and psychosocial approaches, and clinical considerations and future directions.

Author(s):  
CK Foo

Today we are witnessing a significant rise in chronic diseases and chronic pain. Modern medicine appears not to be sufficient to relieve symptoms and reduce or eliminate discomfort. The following proffers the need to look at alternate strategies. In particular, it suggests that a solution might lie if we combine modern technology with ancient wisdom and traditional approaches. This chapter serves to highlight strategies for prudent pain management. “Pain is not just from physical disorders but also from combinations of physiological, pathological, emotional, psychological, cognitive, environmental, and social factors. The keys to successful pain control are the mechanisms that initiate and maintain pain.” “Now, the public and health professionals expect to control pain by using preventive and active strategies, including drugs and physical and psychosocial interventions.” (Holdcroft & Power, 2003).


Author(s):  
Martha Mherekumombe ◽  
John J. Collins

Persistent pain in childhood and medical illness can be challenging to manage. The chapter has been revised to give a brief overview of the approach to pain management in some childhood diseases. Better understanding of the etiology of pain mechanisms guide the management of pain. In addition, an understanding of the pathophysiology of the underlying processes and utilizing a stepwise assessment and treatment approach is important. Discussion around the multifaceted approach to childhood pain management incorporating the understanding of the role and place of analgesics in managing these medical illnesses is outline. In addition, appropriate medication or analgesia prescription and the role of nonpharmacological approaches has been considered in this revision.


F1000Research ◽  
2019 ◽  
Vol 8 ◽  
pp. 107 ◽  
Author(s):  
Mashriq Alganabi ◽  
Carol Lee ◽  
Edoardo Bindi ◽  
Bo Li ◽  
Agostino Pierro

Necrotizing enterocolitis is a devastating intestinal disease affecting preterm infants. In spite of ongoing research and advancement in neonatal care, mortality remains high, especially in infants with advanced disease. The mechanism of disease development, the progression of intestinal injury, and management remain areas of ongoing research and controversy. In this review, we examine our current understanding of the disease, its epidemiology, the risk factors associated with the development of the disease, and its pathophysiology. We also describe current management and new emerging research highlighting potential future directions.


2011 ◽  
Vol 24 (2) ◽  
pp. 136-143 ◽  
Author(s):  
Scott Bennetts ◽  
Evylyn Campbell-Brophy ◽  
Susan Huckson ◽  
Steven Doherty ◽  

Author(s):  
Christopher Eccleston ◽  
Christopher Wells ◽  
Bart Morlion

In this final chapter of European Pain Management the editors summarize what has been learned from taking stock of the experiences in the 37 countries. There are common issues, such as the need to keep pace with the change in demand as demographics change, the requirements for creating specialty status in pain management, and the need to update and innovate with new methods and new science, and the challenges of working within different policy requirements, especially in regard to the control of medicines. There are examples of innovation in practice in all countries. Finally, we discuss the need for greater planning across Europe in order to innovate novel, sustainable models of the organization and delivery of care.


2020 ◽  
pp. bjophthalmol-2019-315651 ◽  
Author(s):  
Darren Shu Jeng Ting ◽  
Valencia HX Foo ◽  
Lily Wei Yun Yang ◽  
Josh Tjunrong Sia ◽  
Marcus Ang ◽  
...  

With the advancement of computational power, refinement of learning algorithms and architectures, and availability of big data, artificial intelligence (AI) technology, particularly with machine learning and deep learning, is paving the way for ‘intelligent’ healthcare systems. AI-related research in ophthalmology previously focused on the screening and diagnosis of posterior segment diseases, particularly diabetic retinopathy, age-related macular degeneration and glaucoma. There is now emerging evidence demonstrating the application of AI to the diagnosis and management of a variety of anterior segment conditions. In this review, we provide an overview of AI applications to the anterior segment addressing keratoconus, infectious keratitis, refractive surgery, corneal transplant, adult and paediatric cataracts, angle-closure glaucoma and iris tumour, and highlight important clinical considerations for adoption of AI technologies, potential integration with telemedicine and future directions.


2018 ◽  
Vol 27 (5) ◽  
pp. 463-467 ◽  
Author(s):  
S. Pathare ◽  
A. Brazinova ◽  
I. Levav

Aim.Treatment gap refers to the percentage of individuals who require treatment in a country or a defined community but do not receive it due to various reasons. There is widespread acceptance of ‘treatment gap’ as a measure of unmet needs in mental health. However, the term ‘treatment’ carries a medical connotation and implies biomedical treatment (or lack of it) of mental illness and is often interpreted by policymakers, planners and researchers, as well as by non-professional stakeholders as exclusively referring to curative clinical psychiatric interventions. This common interpretation results in the exclusion of a range of effective psychosocial interventions available today. Treatment gap also does not include physical health services for persons with mental illness, a major concern due to the relative frequent yet highly unattended physical comorbidity and early mortality of persons with severe mental illness.Methods & Results.We, therefore, propose a more comprehensive measure of unmet needs.


Sign in / Sign up

Export Citation Format

Share Document